Delivery Order SPE2DB20D2014-SPE2DB25FC23F
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Letrozole 2.5 mg tablets (90-count units) valued at $1,081.74. This firm fixed-price delivery order, with an ultimate completion date of July 15, 2025, represents a pediatric continuation under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.999 billion through December 2026. The award involved no set-aside...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Letrozole 2.5 mg tablets in quantities of 90 units, with a ceiling value of $1,248.40. This competitively awarded, firm fixed price delivery order is not set-aside and is scheduled for ultimate completion by August 28, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is a child...
- The Defense Logistics Agency (DLA) awarded a $1,145.15 delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Letrozole 2.5 mg tablets in quantities of 30. The contract, which is a firm fixed price delivery order with no set-aside designation, is scheduled for completion by July 28, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This award represents a competitive procurement action and reflects AmerisourceBergen's role as a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Letrozole 2.5 mg tablets in quantities of 90 units, valued at $1,403.88. This firm fixed price delivery order, which is not set-aside and was competitively awarded, is set for ultimate completion on July 29, 2025. The contract represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to the federal government, with performance occurring at the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Letrozole 2.5 mg tablets in quantities of 90 units, with a contract ceiling value of $2,163.36. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 14, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The contract contains no set-aside designation, indicating the award was made...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Letrozole 2.5 mg tablets in quantities of 30 units, with a ceiling value of $4,624.30. This is a firm fixed-price delivery order with an ultimate completion date of September 11, 2025, and represents a non-competitive set-aside contract. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,116.30 to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Letrozole 2.5 mg tablets in quantities of 90 units. This is a firm fixed price delivery order with no set-aside designation, competitively awarded under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX). The place of performance is AmerisourceBergen's facility in Conshohocken, Pennsylvania, with a completion...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Letrozole 2.5 mg tablets in quantities of 90 units, with a contract ceiling value of $2,110.12. This is a firm fixed price delivery order with an ultimate completion date of September 16, 2025, and was awarded without a set-aside designation through competitive procurement. The place of performance is located in Conshohocken, Pennsylvania, which serves as...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Letrozole 2.5 mg tablets in quantities of 90 units, with a contract ceiling value of $1,136.20. This firm fixed price delivery order, which is set to conclude on August 7, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical product will be delivered to the company's corporate office...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Letrozole 2.5 mg tablets (90-count units) on September 11, 2025, with a ceiling value of $1,448.81 and an ultimate completion date of September 12, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract represents a continuation of AmerisourceBergen's role as...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB25FC23FDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 16, 2025, for the supply of Letrozole 2.5 mg tablets in quantities of 90 units at a firm fixed price of $1,648.08. This non-competitive, competitively awarded contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The delivery order is scheduled for completion by June 17, 2025, with performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical federal vendor for military and veteran healthcare systems. The company's SPE2DX contract serves as a comprehensive global pharmaceutical support vehicle enabling the supply of brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains to support Defense Health Agency programs, the U.S. Coast Guard, and other government healthcare systems worldwide. This specific delivery order for Letrozole, a hormone therapy medication, reflects the breadth of pharmaceutical products the contractor provides through its federal contract portfolio.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 6/16/25 |